End-of-day quote
Other stock markets
|
||
- USD | - |
Apr. 22 | 3Sbio Inc. Announces Management Changes | CI |
Apr. 15 | 3SBIO Gets China Nod for Use of Cancer Injection in Children with Thrombocytopenia | MT |
Business Summary
Sales per Business
HKD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical
100.0
%
| 7,692 | 100.0 % | 7,977 | 100.0 % | +3.71% |
Sales per region
HKD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
China
97.0
%
| 7,522 | 97.8 % | 7,734 | 97.0 % | +2.82% |
Others
3.0
%
| 170 | 2.2 % | 243 | 3.0 % | +42.76% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jing Lou
CEO | Chief Executive Officer | 61 | 92-12-31 |
Xiang He
DFI | Director of Finance/CFO | - | 23-07-02 |
Dong Mei Su
BRD | Director/Board Member | 54 | 12-06-10 |
Bin Huang
BRD | Director/Board Member | 63 | 92-12-31 |
Dong Tao Luo
PRN | Corporate Officer/Principal | 48 | 16-02-29 |
Xin Ma
HRO | Human Resources Officer | 58 | - |
Siu Kuen Lai
SEC | Corporate Secretary | 48 | 14-11-26 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bin Huang
BRD | Director/Board Member | 63 | 92-12-31 |
Jing Lou
CEO | Chief Executive Officer | 61 | 92-12-31 |
Dong Mei Su
BRD | Director/Board Member | 54 | 12-06-10 |
Tian Ruo Pu
BRD | Director/Board Member | 55 | 15-05-31 |
Joo Yeow Ng
BRD | Director/Board Member | 59 | 22-01-20 |
Hoi Ti Yang
BRD | Director/Board Member | 54 | 21-06-28 |
Dan Zhang
BRD | Director/Board Member | 60 | 22-12-29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,438,920,412 | 1,802,803,951 ( 73.92 %) | 40,357,688 ( 1.655 %) | 73.92 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
498,883,645 | 95.20% | 1,578,632,484 $ | |
SENSORION 1.47% | 4,055,150 | 1.47% | 3,367,883 $ |
Company contact information
3SBio, Inc.
Shenyang Economy & Tech Development No. 3 A1, Road 10
110027, Shenyang
+86 24 2538 6000
http://www.3sbio.comGroup companies
Name | Category and Sector |
---|---|
Hongkong Sansheng Medical Ltd.
Hongkong Sansheng Medical Ltd. Pharmaceuticals: MajorHealth Technology Hongkong Sansheng Medical Ltd. develops and commercializes oral disintegration tablet formulation of antipruritic drug. The company is headquartered is Hong Kong. |
Pharmaceuticals: Major
|
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.36B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |
- Stock Market
- Equities
- 1530 Stock
- Stock
- Company 3SBio Inc. (ADR)